We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Hematology Analyzers Offer Channel for Immature Platelet Fraction

By LabMedica International staff writers
Posted on 18 Jul 2012
AACC 2012: A hematology analyzer includes a fluorescent platelet channel for Immature Platelet Fraction (IPF), which will aid in the differential diagnosis of thrombocytopenia. More...
The scalable, series-wide compact design delivers a smaller footprint that improves workflow and transforms productivity.

The analyzers are among products from Sysmex's hematology, urinalysis, cell image analysis, and middleware portfolio that are on show at the annual AACC/AACLS conference Expo being held July 15-19, 2012, in Los Angeles, (CA, USA).

The Sysmex (Mundelein, IL, USA) XN-Series Hematology Analyzers enable laboratories of any size to implement advanced clinical parameters. The scalable, series-wide compact design delivers a smaller footprint that optimizes workflow and transforms productivity. The instruments are built on the concept of Silent Design, a fusion of product design and technology.

Expo in-booth educational presentations will feature topics about hematology technology, diabetes management, and advanced clinical parameters, among others. Sysmex manufactures clinical laboratory solutions, including clinical diagnostics, automation, and information systems, and services hospitals and healthcare networks, reference laboratories, and physicians' offices worldwide.

The Sysmex XN-Series Hematology Analyzer has been designed to enable clinical laboratories to withstand future medical technologist shortages; and the ability to keep up with workload demands and testing complexity that may accompany an aging population. "The human-centered approach of Silent Design, upon which the Sysmex XN-Series hematology analyzers are built, provides a simplified system of operation and interface based on careful study of laboratory processes, the relationship between the operator and the instrument, and how people work," said Ralph Taylor, executive vice president, marketing, business development, and medical affairs, Sysmex America, Inc.

Related Links:

Sysmex America




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Thyroid Test
Anti-Thyroid EIA Test
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.